Authors:
KOOISTRA MP
NIEMANTSVERDRIET EC
VANES A
MOLBEERMANN NM
STRUYVENBERG A
MARX JJM
Citation: Mp. Kooistra et al., IRON-ABSORPTION IN ERYTHROPOIETIN-TREATED HEMODIALYSIS-PATIENTS - EFFECTS OF IRON AVAILABILITY, INFLAMMATION AND ALUMINUM, Nephrology, dialysis, transplantation, 13(1), 1998, pp. 82-88
Authors:
MERKUS MP
JAGER KJ
DEKKER FW
BOESCHOTEN EW
STEVENS P
KREDIET RT
BOEKHOUT M
BARENDREGT J
BULLER HR
DECHARRO FT
VANES A
VANGEELEN JACA
GEERLINGS W
GERLAG PGG
GORGELS JPMC
HUISMAN RM
KONINGMULDER WAH
KOOLEN MI
LEUNISSEN KML
VANLEUSEN R
PARLEVLIET KJ
SCHRODER CH
TIJSSEN JGP
VALENTIJN RM
VINCENT HH
VOS P
Citation: Mp. Merkus et al., QUALITY-OF-LIFE IN PATIENTS ON CHRONIC DIALYSIS - SELF-ASSESSMENT 3 MONTHS AFTER THE START OF TREATMENT, American journal of kidney diseases, 29(4), 1997, pp. 584-592
Authors:
KOOISTRA MP
VANES A
STRUYVENBERG A
MARX JJM
Citation: Mp. Kooistra et al., LOW IRON-ABSORPTION IN ERYTHROPOIETIN-TREATED HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 543-543
Authors:
KOOISTRA MP
VANES A
MARX JJM
HERTSIG MLA
STRUYVENBERG A
Citation: Mp. Kooistra et al., LOW-DOSE ASPIRIN DOES NOT PREVENT THROMBOVASCULAR ACCIDENTS IN LOW-RISK HEMODIALYSIS-PATIENTS DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Nephrology, dialysis, transplantation, 9(8), 1994, pp. 1115-1120